COLOSSUS translational study update
Recruitment to the COLOSSUS translational study will be closing at the end of September 2021. The purpose of the COLOSSUS study is to identify new biomarkers and classifiers for microsatellite stable RAS mutated colorectal cancer. The aim is to develop new diagnostics and therapeutic options for patients bearing this type of cancer after they develop [...]